Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

• Monika Hebeisen,

  Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing

  Affiliations Department of Rheumatology, UniversitätsSpital Zürich, Zurich, Switzerland, Statistics Group, SCQM Foundation, Zurich, Switzerland

  ⨯
• Almut Scherer,

  Roles Data curation, Formal analysis, Supervision

  Affiliation Statistics Group, SCQM Foundation, Zurich, Switzerland

  ⨯
• Raphael Micheroli,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Rheumatology, UniversitätsSpital Zürich, Zurich, Switzerland

  http://orcid.org/0000-0002-8918-7304

  ⨯
• Michael J. Nissen,

  Roles Investigation, Writing – review & editing

  Affiliation Division of Rheumatology, University Hospital Geneva, Geneva, Switzerland

  ⨯
• Giorgio Tamborrini,

  Roles Investigation, Writing – review & editing

  Affiliation Private Center for Sonography and Rheumatology, Basel, Switzerland

  ⨯
• Burkhard Möller,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Rheumatology, Immunology and Allergology, Inselspital, Bern, Switzerland

  ⨯
• Pascal Zufferey,

  Roles Investigation, Writing – review & editing

  Affiliation Division of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  ⨯
• Pascale Exer,

  Roles Investigation, Writing – review & editing

  Affiliation Praxis Rheuma-Basel, Basel, Switzerland

  ⨯
• Adrian Ciurea

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: adrian.ciurea@usz.ch

  Affiliation Department of Rheumatology, UniversitätsSpital Zürich, Zurich, Switzerland

  http://orcid.org/0000-0002-7870-7132

  ⨯